Brief: Oncozenge Intends To Enter Partnership With Pharmanovia For Commercialization Of Bupizenge
18/10/2024 09:02
Oct 18 (Reuters) - Oncozenge AB ONCOZ.ST :
* ONCOZENGE AB INTENDS TO ENTER PARTNERSHIP WITH PHARMANOVIA
FOR
COMMERCIALIZATION OF BUPIZENGE™ IN EUROPE, MIDDLE EAST & NORTH
AFRICA
* GOAL TO SIGN A DEFINITE AGREEMENT BY NOVEMBER 30TH, 2024
* INTENDED AGREEMENT INCLUDES POTENTIAL MILESTONE PAYMENTS,
UP TO
EUR 7 MILLION IN SUPPORT OF PHASE 3 PROGRAM AND
COMMERCIALIZATION FOR BUPIZENGE™
* AGREEMENT WILL INCLUDE COMMERCIAL MILESTONE PAYMENTS AND
ROYALTIES ON PRODUCT SALES
Source text for Eikon: ID:nWkr89L4gV
Further company coverage: ONCOZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))